COVID-19 in the Emergency Department of the Primary Healthcare Centre Banja Luka

Nada Banjac; Ilija Ramić; Snježana Djokić; Tijana Pejić; Igor Korać; Đordje Stojisavljević; Nevena Todorović

doi:10.5937/scriptamed53-36279

Nada Banjac
Ilija Ramić Emergency Medical Care Unit with Educational Centre of Public Health Institution Dom zdravlja Banja Luka
Snježana Djokić Emergency Medical Care Unit with Educational Centre of Public Health Institution Dom zdravlja Banja Luka
Tijana Pejić Emergency Medical Care Unit with Educational Centre of Public Health Institution Dom zdravlja Banja Luka
Igor Korać Emergency Medical Care Unit with Educational Centre of Public Health Institution Dom zdravlja Banja Luka
Đordje Stojisavljević University of Banja Luka
Nevena Todorović University of Banja Luka Faculty of Medicine, Primary Healthcare Centre Banja Luka, Republika Srpska, Bosnia and Herzegovina

DOI: https://doi.org/10.5937/scriptamed53-36279

Keywords: COVID-19, Emergency Department, Outpatient Clinic for Acute Respiratory Infections, Clinical parameters

Abstract

Background / Aim: COVID-19 is acute virus disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS–CoV-2). It was proclaimed as pandemic starting from March 2020 and is still ongoing. COVID-19 pandemic forced all segments of the society, particularly the health sector, to function in changed and aggravating circumstances and because of the transmission and new strains of the virus it resulted in the change of the number of infected people with peaks and oscillations. Aim of this study was to make analysis of the data related to COVID-19 positive/suspect patients examined in the Primary Healthcare Centre Banja Luka in the period 15 March 2020 – 15 March 2021, which refers to the incidence of the infected persons, sex and age representation, laboratory diagnostics and clinical parameters, applied therapy, as well as the number of patients sent for the hospital treatment.

Methods: Data for the analysis were obtained by the retrospective analysis of the statistical data from the electronic medical record of the examined COVID-19 positive/suspect patients in the Outpatient Clinic for Acute Respiratory Infections (ARI) and in the field. Pearson’s χ² test of contingency was used for the comparison of differences of the observed characteristics of the examined groups.

Results: Personnel of the Emergency Department (ED) of the Primary Healthcare Centre Banja Luka, in the period 15 March 2020 – 15 March 2021, examined the total of 3,937 COVID-19 positive patients and patients suspect of COVID-19. Out of that number, 3,601 patients were examined in the ED – ARI and 336 patients were examined in the field. The biggest number of patients was registered in November 2020 (768). Male sex prevailed (55.50 %) and patients of 20-50 years of age were most represented. There were 3.10 % of those highly febrile patients and 2.5 % of those with low SpO₂ of under 90 %. 14.90 % of patients had higher values of troponin T and 45.50 % of them had higher values of D-dimer. In the field, 69.60 % of patients had pathological changes on lungs and 33.30 % had pathological ECG report. The number of patients sent from the ARI for further diagnostic procedure or hospitalisation to the Clinic for Infectious Diseases of the University Clinical Centre of Banja Luka was 1,191 and 258 patients were sent from the field.

Conclusion: For the purpose of preventing the spread of epidemics, the ED reorganised the existing space by introducing temporary clinics – containers for the patients with acute respiratory infections and febrile status, COVID-19 suspects. Clinical parameters changed depending on the new virus strains, as well as on age distribution and infection complications.

References

Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2021 Mar;19(3):141–54.

Chou R, Dana T, Buckley DI, Selph S, Fu R, Totten AM. Epidemiology of and risk factors for coronavirus infection in health care workers. Ann Intern Med 2020 Jul 21;173(2):120–36.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 2020 Feb 22;395(10224):565–74.

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020 Jul 1;5(7):802–10.

Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020 Apr 7;323(13):1239–42.

Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020 Feb 19;368:m606.

Han H, Yang L, Liu R, Liu F, Wu KL, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 2020 Jun 25;58(7):1116–20.

Chen L, Hao G. The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease. Cardiovasc Res 2020 Oct 1;116(12):1932–6.

Fung SY, Yuen KS, Ye ZW, Chan CP, Jin DY. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defense: lessons from other pathogenic viruses. Emerg Microbes Infect 2020;9(1):558–70.

Li D, Chen Y, Jia Y, Tong L, Tong J, Wang W, et al. SARS-CoV-2-induced immune dysregulation and myocardial injury risk in China: insights from the ERS-COVID-19 study. Circ Res 2020 Jul 17;127(3):397–9.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020 Feb 20;382(8):727–33.

De León-Rodríguez SG, Hernández-Rico B, Olmo-Vázquez GD, Cruz-Dávalos I, Bonifaz LC. SARS-CoV-2: previous coronaviruses, immune response and development of vaccines. Bol Med Hosp Infant Mex 2020;77(5):252–61.

Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020 May;46(5):854–87.

Skrbic R, Verhaz A, Kovacevic P, Travar M, KovacevicT, Pelemis M, et al. Guidelines for treating infection caused by the new coronavirus. Banja Luka: Faculty of Medicine; 2020.

Stevanović K. [Corona virus in November: What happened in the most difficult month since the beginning of the pandemic]. Available at: https://www.bbc.com/serbian/lat/srbija-55138088. [Cited:28-Feb-2022]. Serbian.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med 2020 Mar 26;382(13):1199–207.

Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al. Cardiovascular considerations for patients, health care workers and health systems during the COVID-19 pandemic. J Am Coll Cardiol 2020 May 12;75(18):2352–71.

Sorbello M, El-Boghdadly K, Di Giacinto I, Cataldo R, Esposito C, Falcetta S, et al. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice. Anaesthesia 2020 Jun;75(6):724–32.

Leung C. Clinical features of deaths in the novel coronavirus epidemic in China. Rev Med Virol 2020 Mar 16;e2103. doi: 10.1002/rmv.2103.

Shenoy N, Luchtel R, Gulani P. Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting? BMC Med 2020 Aug 19;18(1):260. doi: 10.1186/s12916-020-01735-2.

Garg S, Kim L, Whitaker M, O'Halloran A, Cummings C, Holstein R, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep 2020 Apr 17;69(15):458-64.

Berger JS, Kunichoff D, Adhikari S, Ahuja T, Amoroso N, Aphinyanaphongs Y, et al. Prevalence and outcomes of D-Dimer elevation in hospitalized patients with COVID-19. Arterioscler Thromb Vasc Biol 2020 Oct;40(10):2539–47.

Hosseiny M, Kooraki S, Gholamrezanezhad A, Reddy S, Myers L. Radiology perspective of Coronavirus Disease 2019 (COVID-19): lessons from severe acute respiratory syndrome and middle east respiratory syndrome. AJR Am J Roentgenol 2020 May;214(5):1078–82.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet Lond Engl 2020 Feb 15;395(10223):507–13.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020 Apr 30;382(18):1708–20.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus–infected pneumonia in Wuhan, China. JAMA 2020 Mar 17;323(11):1061–9.